Literature DB >> 11193816

PACAP action in nervous system development, regeneration, and neuroblastoma cell proliferation.

J A Waschek1, E M Dicicco-Bloom, V Lelievre, X Zhou, Z Hu.   

Abstract

Pituitary adenylate cyclase activating peptide (PACAP) may play a role in neurogenesis, nerve injury, and neural tumor growth. A PACAP ligand receptor system functionally coupled to cAMP production was found to be expressed in the embryonic mouse neural tube at the onset of neurogenesis. PACAP was found to inhibit DNA synthesis and antagonize sonic hedgehog signaling in cells isolated from the neural tube, suggesting that PACAP interacts with patterning factors to regulate neurogenesis and phenotypic specification in the developing CNS. PACAP and PACAP receptor (PAC1) mRNA levels were strongly increased and decreased, respectively, in motor neurons in adult rats after facial nerve axotomy, indicating that PACAP may also act in nerve regeneration. Experiments using a neuroblastoma tumor cell line model indicate that PACAP may execute growth-related functions by activating MAP kinase in addition to cAMP-dependent protein kinase A.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193816     DOI: 10.1111/j.1749-6632.2000.tb06959.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Changes in the expression of PACAP-like compounds during the embryonic development of the earthworm Eisenia fetida.

Authors:  Akos Boros; Dora Reglodi; Zsofia Herbert; Gabor Kiszler; Jozsef Nemeth; Andrea Lubics; Peter Kiss; Andrea Tamas; Seiji Shioda; Kouhei Matsuda; Edit Pollak; Laszló Molnar
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

2.  Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line.

Authors:  Tamás Juhász; Csaba Matta; Éva Katona; Csilla Somogyi; Roland Takács; Tibor Hajdú; Solveig Lind Helgadottir; János Fodor; László Csernoch; Gábor Tóth; Éva Bakó; Dóra Reglődi; Andrea Tamás; Róza Zákány
Journal:  J Mol Neurosci       Date:  2014-08-12       Impact factor: 3.444

Review 3.  Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies.

Authors:  Brigitte Onténiente; Sowmyalakshmí Rasika; Alexandra Benchoua; Christelle Guégan
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

4.  Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro.

Authors:  Christine Dufes; Céline Alleaume; Alicia Montoni; Jean-Christophe Olivier; Jean-Marc Muller
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 5.  VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Authors:  J A Waschek
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

6.  Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration.

Authors:  Patricia K Woodley; Qing Min; Yankun Li; Nina F Mulvey; David B Parkinson; Xin-Peng Dun
Journal:  Front Neurosci       Date:  2019-12-12       Impact factor: 4.677

7.  Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.

Authors:  Janna Blechman; Gil Levkowitz
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-21       Impact factor: 5.555

Review 8.  Effects of Pacap on Schwann Cells: Focus on Nerve Injury.

Authors:  Grazia Maugeri; Agata Grazia D'Amico; Giuseppe Musumeci; Dora Reglodi; Velia D'Agata
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.